Charles River (CRL) Beats Q3 Views by 5c; Lowers FY09 EPS Guidance

November 3, 2009 4:27 PM EST

Charles River Laboratories International, Inc. (NYSE: CRL) reports Q3 adjusted EPS of $0.65, 5 cents better than the analyst estimate of $0.60. Revenue for the quarter was $297 million, which compares to the estimate of $306.95 million.

Lower FY09 EPS guidance to $2.28 - $2.32, versus $2.42 consensus.


Related Categories

Earnings
Guidance

Stocks Mentioned

CRL 32.84

+0.44 +1.36%
Volume: 421,726
Track CRL


Add Your Comment